2021
DOI: 10.1021/acsami.1c02072
|View full text |Cite
|
Sign up to set email alerts
|

Development of Aptamer-Based Molecular Tools for Rapid Intraoperative Diagnosis and In Vivo Imaging of Serous Ovarian Cancer

Abstract: Diagnosis and treatment of ovarian cancer are based on intraoperative pathology and debulking surgery. The development of a novel molecular tool is significant for rapid intraoperative pathologic diagnosis, which instructs the decision-making on excision surgery and effective chemotherapy. In this work, we represent a DNA aptamer named mApoc46, which is generated from cell-SELEX by targeting patient-derived primary serous ovarian cancer (pSOC) cells. An average dissociation constant (K d) was determined to be … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(17 citation statements)
references
References 46 publications
0
17
0
Order By: Relevance
“…Moreover, compared to antibodies, versatility of aptamers also permits chemical modifications to be performed at ease for diagnostic and therapeutic applications (Elskens et al 2020;Odeh, et al 2019). Due to their advantages, aptamers are widely used in diagnostics (Liu et al 2021;Citartan 2021), capturing assays (Citartan et al 2016), decontamination processes (Bilibana et al 2017), drug delivery (Thevendran et al 2020;Citartan 2019), therapeutics (Li et al 2021) and in vivo imaging (Wang et al 2021). Aptamers are generated through a process called Systemic Evolution of Ligands via Exponential Enrichment (SELEX).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, compared to antibodies, versatility of aptamers also permits chemical modifications to be performed at ease for diagnostic and therapeutic applications (Elskens et al 2020;Odeh, et al 2019). Due to their advantages, aptamers are widely used in diagnostics (Liu et al 2021;Citartan 2021), capturing assays (Citartan et al 2016), decontamination processes (Bilibana et al 2017), drug delivery (Thevendran et al 2020;Citartan 2019), therapeutics (Li et al 2021) and in vivo imaging (Wang et al 2021). Aptamers are generated through a process called Systemic Evolution of Ligands via Exponential Enrichment (SELEX).…”
Section: Introductionmentioning
confidence: 99%
“…Structure switching sensors such as electrochemical aptamer-based (E-AB) sensors rely on a measurable conformational change of the electrode-bound nucleic acid aptamer in the presence of a target. Aptamers are single-stranded DNA or RNA oligonucleotides selected to bind to a specific target analyte through a process termed SELEX. The interest in the development of aptamer-based sensors is growing because of the ability to detect virtually any analyte of interest through the selection of the nucleic acid sequence specific to the target analyte. However, the functionality of this class of sensing strategies, including electrochemical, aptamer-based sensors, is dependent on the target-induced conformational change of the nucleic acid measured by changes in the faradic current associated with the oxidation/reduction of a redox moiety at the 3′ position of the aptamer.…”
Section: Introductionmentioning
confidence: 99%
“…Since 1990, Tuerk and Ellington [12] applied SELEX technology to obtain aptamers that can specifically recognize T4 DNA polymerase firstly. Aptamers have developed continuously and become a new generation of molecular recognition probes, and it is widely used in medical diagnosis and molecular imaging, [13][14][15] environmental monitoring, [16,17] food safety and other fields. [18][19][20] There are various aptamer screening methods according to different targets, including cell, [21,22] virus [23] and tissue.…”
Section: Introductionmentioning
confidence: 99%